Business / Finance

RSS

Catalyst Health Solutions acquires Walgreens Health Initiatives

Catalyst Health Solutions, Inc. today announced it has completed its acquisition of Walgreens' pharmacy benefit management (PBM) subsidiary, Walgreens Health Initiatives, Inc. (WHI). Catalyst funded the transaction with a combination of cash on hand and amounts available under its credit facility.

13 Jun 2011

Aetna announces acquisition of Genworth's Medicare Supplement business

Aetna today announced that it has entered into an agreement with Genworth Financial, Inc. to acquire Genworth's Medicare Supplement business and related blocks of in-force business. Genworth is a leading provider of Medicare Supplement coverage. The business has more than 145,000 Medicare Supplement members.

13 Jun 2011

Milestone completes $13 million round of equity financing

Milestone Pharmaceuticals Inc., a cardiovascular drug development company, announces the completion of a $13 million round of equity financing.

13 Jun 2011

inVentiv Health acquires i3 CRO

inVentiv Health, Inc., offering best-in-class clinical, consulting and commercial services to the healthcare industry, today announced it has completed the acquisition of i3, a top-tier contract research organization (CRO) to the pharmaceutical, biotech and medical device industries. i3 was previously owned by Ingenix, a UnitedHealth Group company.

13 Jun 2011

Accuray acquires TomoTherapy

Accuray Incorporated announced today that it has completed its previously announced acquisition of TomoTherapy Incorporated.

13 Jun 2011

Trimeris, Synageva enter definitive merger agreement

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, and Trimeris, Inc., announced today that they have entered into a definitive agreement under which Synageva will merge with Trimeris in an all-stock transaction.

13 Jun 2011

Servier, Cortex sign new option agreement for AMPAKINE technology

Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.

13 Jun 2011

Kurma, CRT launch BliNK Therapeutics to generate monoclonal antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

13 Jun 2011

IMS Health acquires Med-Vantage

IMS Health has acquired Med-Vantage, a San Francisco-based software solutions company, to further expand its presence and capabilities in the payer marketplace. Med-Vantage offers its clients a comprehensive suite of provider performance management and member engagement solutions that promote high-quality care and address the complexities of new reimbursement and care delivery models.

10 Jun 2011

PharmAthene to sell $6.5M of common stock and warrants in registered direct offering

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has entered into subscription agreements with certain institutional investors to sell approximately $6.5 million of its common stock and warrants in a registered direct offering.

10 Jun 2011

Amplifon, Rion, William Demant lead $1.4 billion Asia-Pacific retail hearing aid market

According to a new report by iData Research, the leading global authority in medical device market research, the Chinese and Indian markets for hearing devices, including retail and wholesale sales, is valued at over $1 billion and will almost double-in-value by 2017.

10 Jun 2011

Revance closes $45 million financing

Revance Therapeutics, Inc. today announced the closing of a $45 million financing led by Essex Woodlands Health Ventures and new investor, NovaQuest Capital.

10 Jun 2011

Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences (Ambit), an emerging biopharmaceutical company engaged in the development of kinase inhibitors for the treatment of cancer and other conditions, today announced that it has completed a Series D-2 round of equity financing, raising $30 million in new capital.

10 Jun 2011

Centric Health first quarter revenue increases 67% to $23.0 million

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced financial results for the first quarter ended March 31, 2011.

10 Jun 2011

Patheon second quarter revenues decrease 3.1% to $170.0 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today financial results for the second quarter ended April 30, 2011.

10 Jun 2011

lululemon athletica first quarter net revenue increases 35% to $186.8 million

lululemon athletica inc. today announced financial results for the first quarter ended May 1, 2011.

10 Jun 2011

Chinese medical devices market to achieve revenues of $30.6B by 2017

The Chinese medical devices market has enjoyed rapid growth of late and is forecast to achieve revenues of $30.6 billion by 2017, according to a report released on companiesandmarkets.com.

10 Jun 2011

Accuray receives shareholders approval to acquire TomoTherapy

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated by Accuray.

10 Jun 2011

ASI announces successful completion of $10 million round of financing

Access Scientific, Inc. (ASI) today announced the successful completion of a $10 million round of financing. The round was led by CAC and further supported by the company's previous institutional investors.

9 Jun 2011

Birner Dental Management increases quarterly dividend to $.22 per share

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices and Vantage Dental Implant Center, announced its regular quarterly dividend. The Company's board of directors has declared a quarterly cash dividend of 22 cents per share of common stock.

9 Jun 2011